These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 8493449)
41. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines. Müller V; Jensen EV; Knabbe C Cancer Res; 1998 Jan; 58(2):263-7. PubMed ID: 9443403 [TBL] [Abstract][Full Text] [Related]
42. Hypoxia reduces hormone responsiveness of human breast cancer cells. Kurebayashi J; Otsuki T; Moriya T; Sonoo H Jpn J Cancer Res; 2001 Oct; 92(10):1093-101. PubMed ID: 11676860 [TBL] [Abstract][Full Text] [Related]
43. Additive stimulatory action of glucocorticoids and androgens on basal and estrogen-repressed apolipoprotein-D messenger ribonucleic acid levels and secretion in human breast cancer cells. Simard J; de Launoit Y; Haagensen DE; Labrie F Endocrinology; 1992 Mar; 130(3):1115-21. PubMed ID: 1537279 [TBL] [Abstract][Full Text] [Related]
44. Almost exclusive androgenic action of dehydroepiandrosterone in the rat mammary gland. Sourla A; Martel C; Labrie C; Labrie F Endocrinology; 1998 Feb; 139(2):753-64. PubMed ID: 9449650 [TBL] [Abstract][Full Text] [Related]
45. Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells. Hackenberg R; Hofmann J; Hölzel F; Schulz KD J Cancer Res Clin Oncol; 1988; 114(6):593-601. PubMed ID: 2974456 [TBL] [Abstract][Full Text] [Related]
46. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study. Chen J; Wang WQ; Lin SX J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106 [TBL] [Abstract][Full Text] [Related]
47. Involvement of androgen receptor in 17beta-estradiol-induced cell proliferation in rat uterus. Weihua Z; Ekman J; Almkvist A; Saji S; Wang L; Warner M; Gustafsson JA Biol Reprod; 2002 Aug; 67(2):616-23. PubMed ID: 12135905 [TBL] [Abstract][Full Text] [Related]
48. Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture. Vignon F; Bardon S; Chalbos D; Rochefort H J Clin Endocrinol Metab; 1983 Jun; 56(6):1124-30. PubMed ID: 6682424 [TBL] [Abstract][Full Text] [Related]
49. Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells. Arnold JT; Liu X; Allen JD; Le H; McFann KK; Blackman MR Prostate; 2007 Aug; 67(11):1152-62. PubMed ID: 17503469 [TBL] [Abstract][Full Text] [Related]
50. [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines]. Bachmann-Moisson N; Barberi-Heyob M; Merlin JL; Ledrich ML; Batt AM; Guillemin F Bull Cancer; 1996 Oct; 83(10):808-15. PubMed ID: 8952630 [TBL] [Abstract][Full Text] [Related]
51. Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-alpha (TGF-alpha) and epidermal growth factor (EGF)/TGF-alpha receptor. Liu XH; Wiley HS; Meikle AW J Clin Endocrinol Metab; 1993 Dec; 77(6):1472-8. PubMed ID: 8263129 [TBL] [Abstract][Full Text] [Related]
52. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions. van den Berg HW; Martin J; Lynch M Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575 [TBL] [Abstract][Full Text] [Related]
53. Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor. Castagnetta LA; Miceli MD; Sorci CM; Pfeffer U; Farruggio R; Oliveri G; Calabrò M; Carruba G Endocrinology; 1995 May; 136(5):2309-19. PubMed ID: 7536668 [TBL] [Abstract][Full Text] [Related]
54. Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. Zhou J; Ng S; Adesanya-Famuiya O; Anderson K; Bondy CA FASEB J; 2000 Sep; 14(12):1725-30. PubMed ID: 10973921 [TBL] [Abstract][Full Text] [Related]
55. Combined effects of estradiol, leuprorelin, tamoxifen and medroxyprogesterone acetate on cell growth and steroid hormone receptors in breast cancer cells. Sica G; Iacopino F; Robustelli della Cuna G; Marchetti P; Marini L J Cancer Res Clin Oncol; 1994; 120(10):605-9. PubMed ID: 7929532 [TBL] [Abstract][Full Text] [Related]
56. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1. Lykkesfeldt AE; Madsen MW; Briand P Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264 [TBL] [Abstract][Full Text] [Related]
57. The effect of ICI 164384 and beta-interferon on the growth and steroid receptor profile of breast cancer cell lines. Coradini D; Biffi A; Pirronello E; Di Fronzo G Anticancer Res; 1995; 15(6B):2557-61. PubMed ID: 8669823 [TBL] [Abstract][Full Text] [Related]
58. Estrogen down-regulation of androgen receptors in cultured human mammary cancer cells (MCF-7). Stover EP; Krishnan AV; Feldman D Endocrinology; 1987 Jun; 120(6):2597-603. PubMed ID: 3569146 [TBL] [Abstract][Full Text] [Related]
59. Androgen action through estrogen receptor in a human breast cancer cell line. Zava DT; McGuire WL Endocrinology; 1978 Aug; 103(2):624-31. PubMed ID: 744107 [No Abstract] [Full Text] [Related]
60. Estrogen and androgen receptors as comediators of breast cancer cell proliferation: providing a new therapeutic tool. Toth-Fejel S; Cheek J; Calhoun K; Muller P; Pommier RF Arch Surg; 2004 Jan; 139(1):50-4. PubMed ID: 14718276 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]